Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
2020/12/01 by Petra Zimmermann, Nigel Curtis · 28 citations
Medicine · #COVID-19 Clinical Research Studies #Long-Term Effects of COVID-19 #SARS-CoV-2 and COVID-19 Research
paper · pdf · doi:10.1136/archdischild-2020-320338
Abstract
In contrast to other respiratory viruses, children have less severe symptoms when infected with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review, we discuss proposed hypotheses for the age-related difference in severity of coronavirus disease 2019 (COVID-19).Factors proposed to explain the difference in severity of COVID-19 in children and adults include those that put adults at higher risk and those that protect children. The former include: (1) age-related increase in endothelial damage and changes in clotting function; (2) higher density, increased affinity and different distribution of angiotensin converting enzyme 2 receptors and transmembrane serine protease 2; (3) pre-existing coronavirus antibodies (including antibody-dependent enhancement) and T cells; (4) immunosenescence and inflammaging, including the effects of chronic cytomegalovirus infection; (5) a higher prevalence of comorbidities associated with severe COVID-19 and (6) lower levels of vitamin D. Factors that might protect children include: (1) differences in innate and adaptive immunity; (2) more frequent recurrent and concurrent infections; (3) pre-existing immunity to coronaviruses; (4) differences in microbiota; (5) higher levels of melatonin; (6) protective off-target effects of live vaccines and (7) lower intensity of exposure to SARS-CoV-2.
Cited by
- Pre-COVID-19 body mass index and post-acute cardiovascular, gastrointestinal, and neuropsychiatric outcomes among children and young adults with SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER Initiative
- Circulating effector γδ T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals
- Differences Between Children and Adults with COVID-19: It’s Right under Our Nose
- Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children. [europepmc]
- COVID-19: Why does disease severity vary among individuals? [europepmc]
- Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England. [europepmc]
- High Infection Secondary Attack Rates of Severe Acute Respiratory Syndrome Coronavirus 2 in Dutch Households Revealed by Dense Sampling. [europepmc]
- Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? [europepmc]
- Early cross-coronavirus reactive signatures of humoral immunity against COVID-19. [europepmc]
- Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review. [europepmc]
- How Common is Long COVID in Children and Adolescents? [europepmc]
- Neonates and COVID-19: state of the art : Neonatal Sepsis series. [europepmc]
- Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection. [europepmc]
- SARS-CoV-2 viral-load distribution reveals that viral loads increase with age: a retrospective cross-sectional cohort study. [europepmc]
- Robust and durable serological response following pediatric SARS-CoV-2 infection. [europepmc]
- SARS-CoV-2 infections in children: Understanding diverse outcomes. [europepmc]
- Interconnections between Inflammageing and Immunosenescence during Ageing. [europepmc]
- Comparison of Seroconversion in Children and Adults With Mild COVID-19. [europepmc]
- Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea. [europepmc]
- Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C). [europepmc]
- TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1. [europepmc]
- COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes. [europepmc]
- Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). [europepmc]
- The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection. [europepmc]
- Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529). [europepmc]
- The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. [europepmc]
- Wastewater surveillance of SARS-CoV-2 and influenza in preK-12 schools shows school, community, and citywide infections. [europepmc]
- Understanding COVID-19 in children: immune determinants and post-infection conditions. [europepmc]
Related